Mangoceuticals Inc. (MGRX)
NASDAQ: MGRX
· Real-Time Price · USD
1.65
0.14 (8.91%)
At close: Aug 21, 2025, 3:59 PM
1.66
0.61%
After-hours: Aug 21, 2025, 05:59 PM EDT
Mangoceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
Revenue | 516.03K | 511.08K | 615.87K | 755K | 866.79K | 844.87K | 731.49K | 496.06K | 250.9K | 109.66K | 8.94K | n/a | n/a | n/a | n/a |
Cost of Revenue | 201.24K | 216.45K | 235.91K | 312.56K | 362.43K | 323.17K | 299.99K | 202.29K | 101.72K | 47.61K | 4.09K | n/a | n/a | n/a | n/a |
Gross Profit | 314.79K | 294.63K | 379.96K | 442.44K | 504.36K | 521.7K | 431.5K | 293.77K | 149.18K | 62.05K | 4.85K | n/a | n/a | n/a | n/a |
Operating Income | -13.56M | -10.46M | -7.97M | -8.86M | -8.9M | -9.03M | -9.22M | -7.32M | -6.51M | -4.55M | -2.01M | -1.36M | -364.23K | -36.23K | -17.52K |
Interest Income | 13.7K | 13.7K | n/a | n/a | n/a | 8.23K | 8.23K | 8.23K | 8.23K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -14.2M | -11.18M | -8.71M | -9.33M | -9.13M | -9.02M | -9.21M | -7.32M | -6.51M | -4.56M | -2.02M | -1.36M | -366.3K | -37.3K | -17.7K |
Net Income | -14.2M | -11.18M | -8.71M | -9.33M | -9.13M | -9.02M | -9.21M | -7.32M | -6.51M | -4.56M | -2.02M | -1.36M | -366.3K | -37.3K | -17.7K |
Selling & General & Admin | 12.08M | 9.02M | 7.9M | 8.54M | 8.64M | 8.73M | 8.89M | 7.18M | 6.45M | 4.49M | 1.98M | 1.32M | 364.13K | 36.23K | 17.52K |
Research & Development | 360.64K | 360.64K | 532.5K | 694.08K | 505.3K | 636.72K | 464.86K | 131.42K | 162.84K | 31.42K | 31.42K | 31.42K | n/a | n/a | n/a |
Other Expenses | 1.41M | 1.35M | -49.4K | 106.47K | 295.5K | 255.5K | 348K | 348K | 92.5K | 92.5K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 13.85M | 10.73M | 8.35M | 9.3M | 9.41M | 9.55M | 9.65M | 7.62M | 6.66M | 4.61M | 2.02M | 1.36M | 364.13K | 36.23K | 17.52K |
Interest Expense | -187.28K | 13.7K | 13.7K | 464.3K | 222.68K | n/a | 1.76K | 3.56K | 6.65K | 8.23K | 7.36K | 5.74K | 2.65K | 1.07K | 181.00 |
Selling & Marketing Expenses | 937.06K | 908.01K | 1.48M | 1.8M | 2.27M | 2.83M | 2.27M | 1.8M | 1.18M | 383.16K | 98.8K | 98.8K | n/a | n/a | n/a |
Cost & Expenses | 14.07M | 10.97M | 8.59M | 9.62M | 9.77M | 9.87M | 9.95M | 7.82M | 6.77M | 4.66M | 2.02M | 1.36M | 364.13K | 36.23K | 17.52K |
Income Tax Expense | n/a | n/a | -40 | -40 | -40 | -40 | n/a | -3.86K | -3.86K | -3.86K | -3.86K | -71.39K | -71.39K | -71.39K | -71.39K |
Shares Outstanding (Basic) | 9.98M | 1.98M | 1.98M | 2.01M | 1.74M | 1.52M | 1.3M | 1.06M | 1.05M | 750.56K | 885.78K | 997.67K | 997.67K | 997.67K | 997.67K |
Shares Outstanding (Diluted) | 9.98M | 1.98M | 1.98M | 2.01M | 1.74M | 1.52M | 1.3M | 1.06M | 1.05M | 750.56K | 885.78K | 997.67K | 997.67K | 997.67K | 997.67K |
EPS (Basic) | -4.96 | -5.77 | -4.88 | -5.88 | -6.59 | -7.41 | -9.26 | -8.04 | -7.34 | -5.5 | -2.11 | -1.37 | -0.37 | -0.04 | -0.02 |
EPS (Diluted) | -4.96 | -5.77 | -4.82 | -5.82 | -6.53 | -7.28 | -9.19 | -7.97 | -7.27 | -5.5 | -2.11 | -1.37 | -0.37 | -0.04 | -0.02 |
EBITDA | -12.85M | -10.45M | -7.96M | -8.84M | -8.87M | -8.99M | -9.18M | -7.29M | -6.49M | -4.54M | -2.01M | -1.36M | -364.23K | -36.23K | -17.52K |
EBIT | -14.4M | -11.18M | -8.69M | -8.86M | -8.9M | -9.02M | -9.21M | -7.31M | -6.51M | -4.55M | -2.01M | -1.36M | -364.23K | -36.23K | -17.52K |
Depreciation & Amortization | 1.97M | 1.14M | 731.47K | 15.97K | 22.01K | 25.03K | 24.89K | 22.46K | 16.17K | 9.95K | 3.86K | n/a | n/a | n/a | n/a |